Iovance Biotherapeutics (IOVA) Prepaid Assets (2010 - 2026)

Iovance Biotherapeutics (IOVA) has reported Prepaid Assets for 17 consecutive years, with $12.9 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Prepaid Assets fell 18.68% year-over-year to $12.9 million; the TTM figure through Mar 2026 stood at $12.9 million (down 18.68% YoY), while the FY2025 annual figure was $11.6 million, down 6.42% from the prior year.
• Prepaid Assets advanced to $12.9 million in Q1 2026 per IOVA's latest filing, from $11.6 million in the prior quarter.
• Across five years, Prepaid Assets topped out at $17.5 million in Q4 2023 and bottomed at $7.1 million in Q2 2022.
• Historically, Prepaid Assets has averaged $11.5 million across 5 years, with a median of $11.5 million in 2025.
• Annual changes were most pronounced in 2022 — Prepaid Assets sank 31.09% — and 2023, when it surged 140.1%.
• Iovance Biotherapeutics' Prepaid Assets stood at $7.3 million in 2022, then jumped by 140.1% to $17.5 million in 2023, then dropped by 29.1% to $12.4 million in 2024, then decreased by 6.42% to $11.6 million in 2025, then gained by 11.59% to $12.9 million in 2026.
• Business Quant data shows IOVA's Prepaid Assets at $12.9 million in Q1 2026, $11.6 million in Q4 2025, and $9.8 million in Q3 2025.